Antibiotic of Choice for UTI at 24 Weeks Pregnancy
For a 24-week pregnant woman with a UTI, prescribe nitrofurantoin 100 mg twice daily for 5-7 days as first-line therapy, or fosfomycin 3g single dose as an alternative.
Treatment Algorithm
For Uncomplicated Cystitis (Lower UTI)
First-line options:
- Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5-7 days 1, 2
- Fosfomycin trometamol 3g single dose 3, 4
Key considerations:
- Nitrofurantoin demonstrates 98-99% susceptibility against E. coli (the most common pathogen at 82% of pregnancy UTIs) 4
- Fosfomycin shows 98-99% sensitivity for E. coli and 88-89% for Klebsiella species across all trimesters 4
- Recent large cohort data (71,604 pregnancies) found nitrofurantoin had similar malformation risk to β-lactams (RR 1.12,95% CI 0.99-1.26) 5
Second-line options if first-line unavailable:
- Cephalexin or other first-generation cephalosporins for 5-7 days 6, 1
- Amoxicillin-clavulanate 20-40 mg/kg/day in 3 divided doses for 5-7 days 6
For Pyelonephritis (Upper UTI - Fever, Flank Pain, Systemic Symptoms)
Requires hospitalization initially 7:
First-line empirical treatment:
- Second-generation cephalosporins IV (e.g., cefuroxime) 7
Second-line options:
- Aminoglycosides (gentamicin) in second/third trimester - acceptable at 24 weeks 7
- Third-generation cephalosporins IV (e.g., ceftriaxone 1g daily) 8, 7
Transition to oral therapy:
- After 48 hours of clinical improvement and ability to tolerate oral intake 7
- Complete 7-10 days total antibiotic duration 7
Critical Pitfalls to Avoid
Antibiotics to AVOID in Pregnancy
Trimethoprim-sulfamethoxazole (TMP-SMX): Recent high-quality evidence shows increased malformation risk (RR 1.35,95% CI 1.04-1.75), particularly severe cardiac malformations (RR 2.09) and cleft lip/palate (RR 3.23) 5. While older guidelines listed this as acceptable, the 2025 data definitively shows harm.
Fluoroquinolones: Should be avoided due to concerns about fetal cartilage development 8
Nitrofurantoin in specific circumstances:
- Avoid if estimated GFR <30 mL/min (inadequate urinary concentrations)
- Some sources suggest caution near term due to theoretical hemolytic anemia risk in newborns, though at 24 weeks this is not a concern
Common Errors
- Using amoxicillin or ampicillin alone: Very high resistance rates (>20% globally) make these inappropriate for empirical therapy 8
- Treating asymptomatic bacteriuria inadequately: Pregnancy is one of the few conditions where ASB should be treated, but ensure you're treating actual infection, not just cloudy/malodorous urine without symptoms 9
- Insufficient duration: Don't use 3-day courses for pregnant women - minimum 5-7 days even for uncomplicated cystitis 6, 3
Evidence Quality Notes
The recommendation prioritizes nitrofurantoin based on:
- Consistent guideline support across multiple societies 1, 2
- Excellent susceptibility data specific to pregnancy 4, 10
- Recent 2025 safety data from 71,604 pregnancies showing no increased malformation risk 5
- Narrow spectrum minimizing collateral damage 11, 1
Fosfomycin is equally appropriate with single-dose convenience, supported by 2022 meta-analysis of 1,063 pregnant women showing equivalent microbiologic cure to multi-day regimens 3, and excellent susceptibility patterns 4.
The evidence against TMP-SMX is particularly strong given the 2025 population-based cohort study 5, which supersedes older recommendations that listed it as acceptable.
Practical Implementation
Obtain urine culture before starting antibiotics 1, 7, then:
- Start empirical therapy immediately (don't wait for culture)
- Adjust based on susceptibility results if organism shows resistance
- Ensure clinical follow-up to confirm symptom resolution
- Consider suppressive therapy if recurrent UTIs develop (separate consideration)